REVANESSE ULTRA

Serial Number 86648326
Registration 5076190
702

Registration Progress

Application Filed
Jun 2, 2015
Under Examination
Approved for Publication
Aug 23, 2016
Published for Opposition
Aug 23, 2016
Registered
Nov 8, 2016

Trademark Image

REVANESSE ULTRA

Basic Information

Serial Number
86648326
Registration Number
5076190
Filing Date
June 2, 2015
Registration Date
November 8, 2016
Published for Opposition
August 23, 2016
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
702
Status Date
May 12, 2022
Registration
Registered
Classes
005

Rights Holder

Prollenium Medical Technologies, Inc.

03
Address
138 Industrial Parkway North
Aurora, Ontario L4G4C3
CA

Ownership History

Prollenium Medical Technologies, Inc.

Original Applicant
03
Aurora, Ontario CA

Prollenium Medical Technologies, Inc.

Owner at Publication
03
Aurora, Ontario CA

Prollenium Medical Technologies, Inc.

Original Registrant
03
Aurora, Ontario CA

Legal Representation

Attorney
Julie A. Greenberg

USPTO Deadlines

Next Deadline
484 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2016-11-08)
Due Date
November 08, 2026
Grace Period Ends
May 08, 2027

Application History

37 events
Date Code Type Description
Jan 24, 2024 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
May 12, 2022 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 12, 2022 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
May 12, 2022 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Nov 19, 2021 E815 I TEAS SECTION 8 & 15 RECEIVED
Nov 8, 2021 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jan 2, 2019 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 2, 2019 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 17, 2018 CORV 4 REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY ENTERED
Mar 25, 2018 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Nov 8, 2016 R.PR A REGISTERED-PRINCIPAL REGISTER
Aug 23, 2016 PUBO A PUBLISHED FOR OPPOSITION
Aug 23, 2016 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 3, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 21, 2016 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 15, 2016 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 27, 2016 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 27, 2016 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 21, 2016 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Feb 25, 2016 CNSI R SUSPENSION INQUIRY WRITTEN
Feb 25, 2016 GNSI S INQUIRY TO SUSPENSION E-MAILED
Feb 25, 2016 GNS2 O NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Feb 23, 2016 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Feb 19, 2016 ALIE A ASSIGNED TO LIE
Jul 16, 2015 CNEA R EXAMINERS AMENDMENT -WRITTEN
Jul 16, 2015 GNEA O EXAMINERS AMENDMENT E-MAILED
Jul 16, 2015 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 16, 2015 XAEC I EXAMINER'S AMENDMENT ENTERED
Jul 16, 2015 CNSL R SUSPENSION LETTER WRITTEN
Jul 16, 2015 GNSL S LETTER OF SUSPENSION E-MAILED
Jul 16, 2015 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 10, 2015 CNSL R SUSPENSION LETTER WRITTEN
Jul 10, 2015 GNSL F LETTER OF SUSPENSION E-MAILED
Jul 10, 2015 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 3, 2015 DOCK D ASSIGNED TO EXAMINER
Jun 8, 2015 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 5, 2015 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
injectable dermal filler, namely, syringes sold filled with gel for use in cosmetic treatment procedures and wound healing
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"ULTRA"